"Hello everyone, I am Xu Li, and I am also the boss of Suiren Technology. I am very happy to meet you. I am sorry for your company's related experiences, and I also have full authority to formally acquire Xingming Pharmaceutical for 35 million on behalf of Suiren Technology.
, of course our company will also bear your company’s current debts to avoid the risk of bankruptcy.”
Xu Li said to everyone in a low voice.
Currently, Xingming Pharmaceutical’s debt is around 50 million, which is more than enough for Suiren Technology.
The employees were slightly shocked. They didn't expect that their company was actually acquired by Suiren Technology.
But isn’t Suiren Technology in the field of environmental sanitation and semiconductor electronics?
Why did you suddenly enter the medical field?
Even after being acquired, employees are still worried because they are afraid that the new boss Xu Li will directly lay off employees and recruit new employees.
But Xu Li's next words reassured them a lot.
"As for the arrangements for existing employees after the acquisition, they can stay in the company and continue to work. If there are any who want to resign, they need to apply in advance, otherwise it will be regarded as a violation. In addition, the company's rules and regulations and welfare benefits will be changed in due course.
, we will announce and implement it after the New Year, and just wait for notification then."
"Finally, Xingming Pharmaceutical will be renamed Shennong Pharmaceutical, and Mr. Ma Xingming will be appointed as CEO. There will be personnel transfers in the financial department, administrative department and security department, so you don't need to be nervous. In addition, Shennong Pharmaceutical will set up a president's secretary office.
and the Supervision Office, which are responsible for the succession of the president of Suiren Company and the supervision of the company..."
Xu Li explained some matters clearly to avoid any internal disharmony.
For example, the finance department must be mobilized to prevent some people from making false accounts and misappropriating public funds. The security department will also recruit retired soldiers to strengthen security forces.
The Supervision Office and the President's Secretary's Office are independent of each other. The Supervision Office is mainly responsible for verifying various matters of the company every month, including financial information, administrative personnel review and review, technical department information review and supervision, etc.
Xu Li is not doing this just for fun. If the company develops in the future, it will inevitably happen like that of some large companies, so we still need to do something to prevent it.
Especially important departments such as finance and technology departments, one is responsible for the company's financial affairs, and the other is responsible for the development and innovation of technical products. It is impossible to ignore either one.
In addition, he plans to wait until the time is right to implement a rule within the company. For all middle and high-level management of the company, whoever is responsible for that position will be responsible for that responsibility. They are not allowed to overstep their duties and interfere with the work of other departments at will. Administrative personnel can only be responsible for administrative matters.
As well as a small number of administrative review matters, other technical work must not be interfered with, otherwise it will be considered a violation.
After listening to Xu Li's words, everyone was confused and relaxed.
What puzzles me is the changes in the company that Xu Li just mentioned, but these are not important for the time being. What is relaxing is that their old boss is still in charge of their company, and they are relatively familiar with each other.
"By the way, one last thing. Since the changes I just mentioned will not be officially implemented until after the New Year, the existing company's business will be suspended for the rest. I will ask someone to transfer the funds to Shennong Pharmaceutical's bank account.
Yes, we will settle the salaries and year-end bonuses of the company’s employees within this week and take the holidays in advance!”
Xu Li felt that it was almost the Chinese New Year, and the employees of Suiren Technology were on vacation, and Shennong Pharmaceutical was no exception.
I just took this opportunity to update various equipment and systems in the company, revamp them, and connect them to the office application system of Suiren Technology, so that unified coordination, clear division of labor, and effective supervision can be achieved.
After saying this, Xu Li turned around and went to the president's office. He still needed to talk to Ma Xingming about other things.
After seeing Xu Li leave, the quiet employees suddenly burst into joy.
"Great!"
“I didn’t expect that the new owner would let us take an early holiday!”
"I thought I would have to work again until one week before the Chinese New Year before I have a holiday."
“What an unexpected surprise!”
"Then we also have winter vacation~"
Looking at the noisy employees, Ma Xingming felt helpless, then he coughed and said to everyone:
"Okay, stop making trouble. Although the chairman has announced an early holiday, you still need to complete the remaining finishing work within this week, otherwise it will be a delay."
With Ma Xingming's reminder, all the employees came back to their senses and returned to their posts, preparing to increase their efforts to complete the remaining work.
Ma Xingming nodded when he saw this, and then went to the president's office.
But he was a little nervous. Although Xu Li asked him to become the company's president again and lost the company's real power, he didn't know what kind of pressure he would face next.
He felt a little uneasy.
"Sit down, old horse."
Xu Li motioned to Ma Xingming to sit down and talk.
Ma Xingming nodded and sat opposite Xu Li.
"Lao Ma, what do you think of the company's development?"
"Um... In this case, the company currently produces generic drugs and authorized drugs, plus some sanitary equipment, which may make profits in the short term, but in my opinion it is not a long-term solution. Chairman, do you want to invest in the research and development of new drugs?
”
Ma Xingming asked speculatively.
Although he was originally the boss of a company, he also graduated with a pharmacy major, so he naturally knows how difficult it is to develop new drugs.
At present, a large part of life-saving drugs are basically monopolized by foreign countries, and some key drugs and their manufacturing technologies are also controlled by top multinational pharmaceutical companies such as Pfizer, Johnson & Johnson, Roche, Merck, and Glaxo.
Although there are many domestic research institutions and even national universities and their academies of sciences that have made repeated breakthroughs in the field of medicine, there is still a gap compared with these giants.
This not only refers to the gap in funding, but also the gap in R&D investment.
According to statistics, many domestic pharmaceutical companies spend most of their expenses on sales and invest very little in R&D and innovation, resulting in a lack of coordination between R&D investment and sales investment, which may not lead to a certain improvement in effectiveness.
If this was a start-up pharmaceutical company, it would be understandable from its development and management standpoint.
Because for start-up pharmaceutical companies, they often need to carry out commercialization before they can obtain revenue, so sales expenses are front-loaded compared to revenue.
However, the revenue scale of many leading innovative pharmaceutical companies is already high, but the sales expense ratio is still high.
In addition, there are also gaps in technology and equipment.
You must know that medicine is a big field. If you want to develop innovative breakthroughs, you must be willing to invest money, purchase high-end research and experimental instruments, improve the accuracy of experimental data, and speed up the progress of research and innovation.
However, this kind of high-end equipment basically relies on foreign imports, and we need to work hard on this.
"Yes, some of the company's reforms and changes this time are to prepare for the research and development of a new drug. As for the general information, you can take a look. I also brought the documents."
Xu Li handed him the outline plan document that he had prepared.
Ma Xingming took it and started to look through it.
To be honest, he is not optimistic about medical innovation and research and development, because it is obviously difficult and, to some extent, more expensive than the Internet.
Just when he was thinking this, his eyes had already fallen on the document.
Then shocked eyes appeared, and he asked Xu Li in disbelief:
"Chairman, are we going to make anti-cancer drugs? Is there any progress?"